HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via Google Scholar Google Scholar Search for Related Content Related Collections Related Article

Ann Thorac Surg 2000;69:350
© 2000 The Society of Thoracic Surgeons

---

Discussions

Discussion

DR JOHN H. CALHOON (San Antonio, TX): My thanks to Dr Pham and his colleagues from Pittsburgh on a nicely presented series, which should cause us all to reevaluate our lung transplant practice. One question to Dr Pham, about a manuscript and presentation that was very complete and well done, why do you think there was a difference in the biopsy incidence of obliterative bronchiolitis and the incidence of true bronchiolitis obliterans syndrome?

The other question would center around, where do we go from here? What do you think the optimum time of donor marrow transfusion would be? How would you best augment the engraftment? Would you use cytolytics, consider total lymphoid irradiation, the amount of infusion and/or, as I mentioned, its timing?

I would like to thank Dr Pham and his colleagues for this presentation and its contribution to our Society and profession.

. . . [Full Text of this Article]

Related Article

Effects of donor bone marrow infusion in clinical lung transplantation

Si M. Pham, Abdul S. Rao, Adriana Zeevi, Kenneth R. McCurry, Robert J. Keenan, J. David Vega, Robert L. Kormos, Brack G. Hattler, John J. Fung, Thomas E. Starzl, and Bartley P. Griffith
Ann. Thorac. Surg. 2000 69: 345-350. [Abstract] [Full Text] [PDF]